Hans Hofland

Company: Turn Biotechnologies

Job title: Senior Vice President - Preclinical Development

Bio:

Dr. Hofland is the SVP of Pre-Clinical Development at Turn Biotechnologies, has worked with more than a dozen leading dermatology and Immunology companies. He most recently worked at Evommune, a clinical-stage biotechnology company he co-founded and served as senior vice president of research. Previously, Dr. Hofland headed Research and Nonclinical Development at Dermira, where he worked for more than seven years until the company’s acquisition by Eli Lilly. He earlier held the position of senior director of GlaxoSmithKline’s Center for Skin Biology, a position he also held under Stiefel Laboratories prior to its acquisition by GlaxoSmithKline. During his productive career, Dr. Hofland has been involved with 13 INDs and helped bring 10 different products to market. He holds 21 granted and pending patents and has written more than 25 scientific journal articles. Dr. Hofland received his doctorate in Pharmaceutical Sciences from the University of Leiden in the Netherlands.

Seminars:

Up in ARMMs – A Novel Delivery System for Multiple Payloads 3:00 pm

What are ARMMs Gene Editing for Stargardt Disease Other potential clinical uses for ARMMs NEW DATA!Read more

day: Conference Day Two